Warning Letters Week of 06/14/20: Data Integrity
FDA appears to be catching up a bit after a couple of very slow weeks for warning letters issued for drugs, biologics, devices, and compounding pharmacies. This week FDA posted one warning letter to a device firm, two to compounding pharmacies, one to an HCT/P manufacturer, and two to drug firms. Normally we don’t publish […]